We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Aims Warning Letters at Makers of Unapproved COVID-19 Treatments
FDA Aims Warning Letters at Makers of Unapproved COVID-19 Treatments
The FDA is targeting unapproved drug products that are used for prevention or treatment of COVID-19 infections and has issued at least seven warning letters since early July, for three nasal or oral sprays, two hand sanitizers and two other drugs.